India Plan For Generics Pharmacies Estimates Large Cost Savings
This article was originally published in PharmAsia News
Executive Summary
The Indian government's plan to establish a network of retail generics pharmacies around the country is expected to lower the costs of some drugs by as much as 93 percent. A study by the pharmaceutical department shows that by offering an alternative to the traditional ties pharmacies have with drug makers, the cost of drugs to the buyer could be driven lower. A government draft report compares the cost of generics of specific medicines with the branded versions to reach an estimate of the cost savings. (Click here for more
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.